HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fungicidal activity plus reservoir effect allow short treatment courses with terbinafine in tinea pedis.

Abstract
Terbinafine, a synthetic allylamine, exerts fungicidal activity against dermatophytes, the causative pathogens of tinea pedis. As proven in numerous clinical trials, tinea pedis can be effectively and safely treated by topical terbinafine. In fact, a 1-week application of terbinafine 1% cream eradicated fungal pathogens at least as effectively as 4-week treatment courses with topical azole derivative antifungals and showed lower relapse rates. A new innovative single-application formulation of terbinafine 1% in a film-forming solution produces a high concentration gradient on the skin surface and enables a prolonged (up to 13 days) exposure of the skin to terbinafine. High drug penetration into the skin results in an otherwise not obtained drug reservoir in the horny layer, the location of dermatophytes in tinea pedis. Although azole antimycotics can also effectively penetrate into the horny layer of the skin, short-term therapy might not be feasible due to its primarily fungistatic activity against dermatophytes. Thus, we conclude that the high efficacy of short-term treatment with terbinafine in patients with tinea pedis is possible due to its fungicidal activity coupled with a distinct reservoir formation in the upper layers of the epidermis.
AuthorsM Schäfer-Korting, C Schoellmann, H C Korting
JournalSkin pharmacology and physiology (Skin Pharmacol Physiol) Vol. 21 Issue 4 Pg. 203-10 ( 2008) ISSN: 1660-5535 [Electronic] Switzerland
PMID18509254 (Publication Type: Journal Article, Review)
Copyright(c) 2008 S. Karger AG, Basel.
Chemical References
  • Antifungal Agents
  • Delayed-Action Preparations
  • Naphthalenes
  • Terbinafine
Topics
  • Administration, Topical
  • Antifungal Agents (administration & dosage, pharmacokinetics, therapeutic use)
  • Clinical Trials as Topic
  • Delayed-Action Preparations
  • Drug Administration Schedule
  • Half-Life
  • Humans
  • Naphthalenes (administration & dosage, pharmacokinetics, therapeutic use)
  • Skin Absorption
  • Terbinafine
  • Tinea Pedis (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: